Market Analysis and Insights: Global Tricuspid Valve Repair Device Market
Due to the COVID-19 pandemic, the global Tricuspid Valve Repair Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Tricuspid Valve Replacement Devices accounting for % of the Tricuspid Valve Repair Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Tricuspid Valve Repair Device market size is valued at US$ million in 2021, while the US and Europe Tricuspid Valve Repair Device are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Tricuspid Valve Repair Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Tricuspid Valve Repair Device include Medtronic, Edwards Lifesciences, Abbott Laboratories, St. Jude Medical, LivaNova, JenaValve, Neovasc, Micro Interventional Devices and Colibri Heart Valve and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Tricuspid Valve Repair Device Scope and Segment
Tricuspid Valve Repair Device market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Tricuspid Valve Repair Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Tricuspid Valve Replacement Devices
Tricuspid Valve Repair Devices
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Company
Medtronic
Edwards Lifesciences
Abbott Laboratories
St. Jude Medical
LivaNova
JenaValve
Neovasc
Micro Interventional Devices
Colibri Heart Valve
CryoLife
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE